Volume 32, Issue 6 e13823
ORIGINAL ARTICLE

Endoscope presence during endoluminal functional lumen imaging probe (FLIP) influences FLIP metrics in the evaluation of esophageal dysmotility

Amanda Bianca

Amanda Bianca

Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland

Search for more papers by this author
Valeria Schindler

Valeria Schindler

Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland

Division of Internal Medicine, Stadtspital Triemli, Zurich, Switzerland

Search for more papers by this author
Larissa Schnurre

Larissa Schnurre

Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland

Search for more papers by this author
Fritz Murray

Fritz Murray

Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland

Search for more papers by this author
Daniel Runggaldier

Daniel Runggaldier

Department of Otorhinolaryngology, University Hospital of Zurich, Zurich, Switzerland

Search for more papers by this author
Chandra Prakash Gyawali

Chandra Prakash Gyawali

Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri, USA

Search for more papers by this author
Daniel Pohl

Corresponding Author

Daniel Pohl

Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland

Correspondence

Daniel Pohl, Lead Functional Diagnostic Center, Division of Gastroenterology and Hepatology, University Hospital Zurich, Raemistr. 100, 8091 Zurich, Switzerland.

Email: [email protected]

Search for more papers by this author
First published: 25 February 2020
Citations: 15

Funding information

No funding and/or material support.

Abstract

Background

The functional lumen imaging probe (FLIP) system is an FDA-approved tool for dynamic evaluation of the esophagogastric junction (EGJ). Even though commercially available since 2009, FLIP utilization remains low, partly due to lack of consensus in methodology and interpretation. Therefore, we aimed to analyze the influence of concurrent endoscopy on FLIP measurements.

Methods

In this single-center study, we reviewed data from 93 patients undergoing FLIP for symptomatic esophageal motility disorders between 2016 and 2018. During sedated endoscopy, we measured luminal values (distensibility, cross-sectional area (CSA), and balloon pressure) at the EGJ and distal esophagus using 30, 40, and 50 mL distension volumes, with and without concurrent endoscope presence. All recorded values were compared at the various distension volumes between the two measurements using a Wilcoxon rank sum test.

Key Results

There was a significant difference in distensibility and CSA with index distension volume (40 mL) at the EGJ comparing the two measurements: Lower median distensibility was 2.1 mm2 mm Hg−1 in the group with concurrent inserted endoscope, respectively, 3.4 mm2 mm Hg−1 without endoscope (P < .001), and median CSA was 86.0 resp. 110.0 mm2 (P < .001). No significant difference could be found in the measurements of the distal esophagus.

Conclusions & Inferences

Our results show a significant difference in FLIP measurements with and without endoscope presence. This underlines the importance of establishing a consensus of a standardized FLIP protocol to define normal luminal values and guiding future FLIP diagnostic studies.

CONFLICT OF INTEREST

Chandra Prakash Gyawali: Medtronic (Consultant), Diversatek (Consultant), Ironwood (Consultant), Quintiles (Consultant), Isothrive (Consultant), and Daniel Pohl: Medtronic (Consultant). No other conflicts of interest exist.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.